COGT compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

COGTCogent Biosciences, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

COGTCogent Biosciences, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

COGT

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.6%▼−2.03%×0.21

Q1 FY26±9.5%▲+0.68%×0.07

Feb 17 '26±7.5%▲+2.98%×0.40

Q3 FY25±37.0%▼−4.91%×0.13

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedCOGT realized, solidLLY realized, hatchedOne scale, both sides: full bar = 37%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

COGTCogent Biosciences, Inc.

29.74· pre 29.70· delayed

Mkt cap$5.2BRevenue—Revenue—

LLYELI Lilly & Co

1,418.01· pre 1,396.65

Pre-marketNov 3 '26

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Pre-marketNov 3 '26

COGTCogent Biosciences, Inc.

LLYELI Lilly & Co

29.74pre 29.70delayed

Price

1,418.01pre 1,396.65

$5.2B

Mkt cap

$1.3T

—

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

COGT29.74vsLLY1,418.01Pre-marketNov 3 '26